Zoledronic acid seems to reduce risk of repeat breaks and death after hip fracture
AUTOR(ES)
Tanne, Janice Hopkins
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1988998Documentos Relacionados
- UK hip fracture audit is launched to improve care and reduce costs
- Do beta-blockers and thiazides reduce fracture risk?
- Risk Factors for Severity and Type of the Hip Fracture
- Hip fracture risk and different gene polymorphisms in the turkish population
- Hormone replacement therapy and risk of hip fracture: population based case-control study